Article
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
Journal of gastroenterology - 1 Apr 2016
Ueyama Misuzu, Nishida Nao, Korenaga Masaaki, Korenaga Keiko, Kumagai Erina, Yanai Hidekatsu, Adachi Hiroki, Katsuyama Hisayuki, Moriyama Sumie, Hamasaki Hidetaka, Sako Akahito, Sugiyama Masaya, Aoki Yoshihiko, Imamura Masatoshi, Murata Kazumoto, Masaki Naohiko, Kawaguchi Takumi, Torimura Takuji, Hyogo Hideyuki, Aikata Hiroshi, Ito Kiyoaki, Sumida Yoshio, Kanazawa Akio, Watada Hirotaka, Okamoto Koji, Honda Kenjiro, Kon Kazuyoshi, Kanto Tatsuya, Mizokami Masashi, Watanabe Sumio
Abstract excerpt
BACKGROUND: Type 2 diabetes mellitus (T2DM) is an established independent risk factor for hepatocellular carcinoma (HCC). T2DM is associated with non-alcoholic steatohepatitis (NASH), which is a major cause of non-HBV and non-HCV-related HCC; nevertheless, it has been difficult to identify those patients with T2DM who have a high risk of developing HCC. The aim of this study was to identify genetic determinants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
